Company: ATXA Therapeutics
Done Deal:€2.5m funding
The clincher:“There is urgent unmet clinical need with regard to PAH, because the current drugs don’t work. They are failing patients” – Therese Kinsella, founder
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team